James Basta

2021 - Intellia Therapeutics

In 2021, James Basta earned a total compensation of $15.1M as Executive Vice President, General Counsel and Corporate Secretary at Intellia Therapeutics.

Compensation breakdown

Bonus$235,200
Option Awards$14,612,637
Salary$219,692
Other$5,430
Total$15,072,959

Basta received $14.6M in option awards, accounting for 97% of the total pay in 2021.

Basta also received $235.2K in bonus, $219.7K in salary and $5.4K in other compensation.

Rankings

In 2021, James Basta's compensation ranked 533rd out of 12,397 executives tracked by ExecPay. In other words, Basta earned more than 95.7% of executives.

ClassificationRankingPercentile
All
533
out of 12,397
96th
Division
Manufacturing
177
out of 5,492
97th
Major group
Chemicals And Allied Products
56
out of 2,367
98th
Industry group
Drugs
50
out of 2,090
98th
Industry
In Vitro and In Vivo Diagnostic Substances
1
out of 61
98th
Source: SEC filing on May 2, 2022.

Basta's colleagues

We found four more compensation records of executives who worked with James Basta at Intellia Therapeutics in 2021.

2021

John Leonard

Intellia Therapeutics

Chief Executive Officer

2021

Laura Sepp-Lorenzino

Intellia Therapeutics

Chief Scientific Officer

2021

David Lebwohl

Intellia Therapeutics

Chief Medical Officer

2021

Glenn Goddard

Intellia Therapeutics

Chief Financial Officer

News

In-depth

You may also like